{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:32:59Z","timestamp":1787160779760,"version":"build-2736575974"},"reference-count":20,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"SEED Funding Singhealth Polyclinics"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,7,20]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>Serum potassium is part of routine laboratory tests done for patients with hypertension or diabetes mellitus in primary care. Those found to have raised potassium (K&gt;5.5 mmol\/L) are recalled for repeat potassium in emergency departments or primary care clinics. Repeat potassium are often normal (\u22645.5 mmo\/L), that is, false hyperkalaemia. Haemolysis is known to cause false hyperkalaemia. We postulated that unlysed false hyperkalamia was prevalent and was associated with factors such as delayed processing time.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to determine the prevalence of unlysed false hyperkalaemia and the factors associated with false-and-true-hyperkalaemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Outpatients in a cluster of public primary care clinics (polyclinics) in Singapore.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>All patients of any ethnicity aged \u226521 with serum potassium test done.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Electronic health records of index patients with potassium &gt;5.5 mmol\/L and its corresponding laboratory processing time in seven local polyclinics were reviewed between August 2015 and August 2017. Haemolysed specimens and patients on sodium polystyrene sulfonate (SPS) suspension were excluded. If repeat potassium level was \u22645.5 mmol\/L within 8 days, the case was defined as false hyperkalaemia. The proportion of such patients was computed to determine its prevalence. Linear and logistic regressions were used to identify the associated factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study population comprised of 3014 index cases, of which 1575 had repeat potassium tests without preceding SPS. 86.4% (1362\/1575) of them had potassium \u22645.5 mmol\/L. The average processing time among specimens with potassium \u22656.0 mmol\/L was 50 min longer, compared with those with potassium &lt;5.1 mmol\/L. Risk factors significantly associated with false hyperkalaemia included estimated glomerular filtration rate (eGFR) (60\u201389 mL\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      , OR=3.25, p&lt;0.001;&gt;90 mL\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      , OR=3.77, p&lt;0.001) and delayed laboratory processing time (beta coefficient 0.001, p&lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The prevalence of false hyperkalaemia was 86.4%. Recommendation to repeat potassium tests may target those with eGFR&lt;60ml\/min\/1.73m\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-033755","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T19:18:19Z","timestamp":1600802299000},"page":"e033755","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence and factors associated with false hyperkalaemia in Asians in primary care: a cross-sectional study (the Unlysed Hyperkalaemia- the Unseen Burden (UHUB) study)"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6099-3452","authenticated-orcid":false,"given":"Alicia Ying Ying","family":"Boo","sequence":"first","affiliation":[{"name":"Family Medicine, National University Polyclinics, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Ling Eileen","family":"Koh","sequence":"additional","affiliation":[{"name":"Research, SingHealth Polyclinics, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Lin","family":"Hu","sequence":"additional","affiliation":[{"name":"Family Medicine, SingHealth Polyclinics, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5946-1149","authenticated-orcid":false,"given":"Ngiap Chuan","family":"Tan","sequence":"additional","affiliation":[{"name":"Research, SingHealth Polyclinics, Singapore"},{"name":"SingHealth-Duke NUS Medical School Academic Clinical Programme, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"2026062608022721000_10.9.e033755.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61506-1"},{"key":"2026062608022721000_10.9.e033755.2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.368"},{"key":"2026062608022721000_10.9.e033755.3","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/12-088"},{"key":"2026062608022721000_10.9.e033755.4","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/clinchem\/40.11.1996","article-title":"Interference with clinical laboratory analyses","volume":"40","author":"Kroll","year":"1994","journal-title":"Clin Chem"},{"key":"2026062608022721000_10.9.e033755.5","doi-asserted-by":"publisher","DOI":"10.1177\/0004563212474566"},{"key":"2026062608022721000_10.9.e033755.6","first-page":"297","article-title":"Spurious hyperkalaemia: an insight","volume":"61","author":"Zaki","year":"2011","journal-title":"J Pak Med Assoc"},{"key":"2026062608022721000_10.9.e033755.7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.clinbiochem.2014.08.019","article-title":"Seasonal factitious increase in serum potassium: still a problem and should be recognised","volume":"47","author":"Davis","year":"2014","journal-title":"Clin Biochem"},{"key":"2026062608022721000_10.9.e033755.8","first-page":"CC01","article-title":"Delay in specimen processing-major source of preanalytical variation in serum electrolytes","volume":"8","author":"Baruah","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"2026062608022721000_10.9.e033755.9","first-page":"547","article-title":"A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers","volume":"5","author":"Sadjadi","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"2026062608022721000_10.9.e033755.10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/jcpt.12720","article-title":"Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments","volume":"43","author":"Hirai","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"2026062608022721000_10.9.e033755.11","article-title":"Hypokalemia: a clinical update","author":"Kardalas","journal-title":"Endocr Connect"},{"key":"2026062608022721000_10.9.e033755.12","unstructured":"Government of Singapore . Singapore Ministry of Health Primary Care Survey, 2014. Available: https:\/\/www.moh.gov.sg\/resources-statistics\/reports\/primary-care-survey-2014-report"},{"key":"2026062608022721000_10.9.e033755.13","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03640415"},{"key":"2026062608022721000_10.9.e033755.14","doi-asserted-by":"publisher","DOI":"10.1097\/01.SMJ.0000149407.51134.77"},{"key":"2026062608022721000_10.9.e033755.15","doi-asserted-by":"publisher","DOI":"10.1177\/1062860605285047"},{"key":"2026062608022721000_10.9.e033755.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2014.04.019"},{"key":"2026062608022721000_10.9.e033755.17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/ejhf.1199","article-title":"Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists","volume":"20","author":"Trevisan","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026062608022721000_10.9.e033755.18","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13421","article-title":"Associations between serum potassium and adverse clinical outcomes: a systematic literature review","volume":"74","author":"Palaka","year":"2020","journal-title":"Int J Clin Pract"},{"key":"2026062608022721000_10.9.e033755.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184402","article-title":"Incidence of and risk factors for newly diagnosed hyperkalemia after hospital discharge in non-dialysis-dependent CKD patients treated with Ras inhibitors","volume":"12","author":"Saito","year":"2017","journal-title":"PLoS One"},{"key":"2026062608022721000_10.9.e033755.20","unstructured":"Palevsky PM . Acute kidney injury: complications associated with acute kidney injury. nephrology hypertension, 2017. Available: https:\/\/www.renalandurologynews.com\/home\/decision-support-in-medicine\/nephrology-hypertension\/acute-kidney-injury-complications-associated-with-acute-kidney-injury\/"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-033755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:09:05Z","timestamp":1782486545000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-033755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,22]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/bmjopen-2019-033755"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-033755","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}